Population pharmacokinetics of lisinopril in hypertensive children and adolescents with normal to mildly reduced kidney function.
Louis SandraEva DegraeuwePauline De BruyneSiegrid De BaereSiska CroubelsJan Van BocxlaerAnn RaesJohan Vande WalleElke GasthuysAn VermeulenPublished in: British journal of clinical pharmacology (2023)
Lisinopril dose and regimen adjustments for pediatric patients should include eGFR on top of weight adjustments. An expanded model characterizing the pharmacodynamic effect is required to identify the optimal dose and dosing regimen.